Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia

Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia

Background: About 4 out of 10 fibromyalgia patients suffer from depression. The European Alliance of Associations for Rheumatology (EULAR) guidelines recommend using antidepressants to treat fibromyalgia. Objective: To determine predictors of improved outcomes following a multicomponent treatment pr...

Full description

Bibliographic Details
Main Authors: Bala Munipalli, Madeleine E. Allman, Mohit Chauhan, Shehzad K. Niazi, Fernando Rivera, Andy Abril, Benjamin Wang, Mikolaj A. Wieczorek, David O. Hodge, Dacre Knight, Adam Perlman, Abd Moain Abu Dabrh, Daniel Dudenkov, Barbara K. Bruce
Format: Article
Language:English
Published: SAGE Publishing 2022-08-01
Series:Journal of Primary Care & Community Health
Online Access:https://doi.org/10.1177/21501319221120738

Internet

https://doi.org/10.1177/21501319221120738

Similar Items